Evidence map›Paper›PMID 34729647›Full record

ArticleCell and tissue research2022

The specialized mitotic behavior of human embryonic stem cells.

Rui Lyu, Xuemei Wu, Nan Ma, Difei Wang, Shuang Sun, Youguang Luo, Jun Zhou, Xinyi Lu, Min Liu, Dengwen Li

Abstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Compromised Mitotic Fidelity in Human Pluripotent Stem Cells.International journal of molecular sciences · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rui Lyu *Tianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China.
Xuemei Wu *Tianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China.
Nan MaTianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China.
Difei WangTianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China.
Shuang SunShandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Jinan, 250014, China.
Youguang LuoShandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Jinan, 250014, China.
Jun ZhouTianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China.
Xinyi LuTianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China.
Min LiuShandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Jinan, 250014, China. minliu@sdnu.edu.cn.
Dengwen LiTianjin Key Laboratory of Protein Science, State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Pharmacy, Nankai University, Tianjin, 300071, China. dwli@nankai.edu.cn.ORCID http://orcid.org/0000-0002-4573-7191
Nankai University · CNShandong Normal University · CN

Funding

Key Technologies Research and Development Program 2018YFA0107001National Natural Science Foundation of China 31771542National Natural Science Foundation of China 31871347National Natural Science Foundation of China 32000490National Natural Science Foundation of China 32000870the Key Laboratory of Immune Microenvironment and Disease (Tianjin Medical University), Ministry of Education 20190204
6 · The paper itself

Abstract

Human embryonic stem cells (hESCs) are self-renewing and pluripotent cells that originate from the inner cell mass of the blastocyst. Mitosis is fundamental to organism survival and reproduction and is responsible for the equal distribution of duplicated chromosomes into daughter cells. Mitotic dysfunction is associated with a wide variety of human diseases, not least cancer. hESCs have a unique cell cycle distribution, but it is unclear exactly how the mitotic activity of hESCs is related to their proliferation and differentiation. Here, we established a cell line of hESCs stably expressing GFP-α-tubulin and mCherry-H2B by lentiviral infection to analyze and visualize mitosis in detail. During metaphase, the mitotic spindle was smaller and wider and contained a greater proportion of astral microtubules than normal cells. In addition, spindle microtubules were more stable, and chromosome alignment was faster in hESCs than in somatic cells. We also found that the spindle assembly checkpoint was functional in hESCs. These findings thus reveal a specialized mitotic behavior of hESCs.

Indexed as

HeLa CellsHuman Embryonic Stem CellsHumansMitosisChromosomeEmbryonic stem cellMitosisSpindle assembly checkpointSpindle microtubule

Identifiers

PMID34729647
OpenAlexW3209737964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.